One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Rare diseases: maintaining momentum
The Lancet Neurology
doi : 10.1016/S1474-4422(22)00046-1
Volume 21, Issue 3, March 2022, Page 203
Riluzole and spinocerebellar ataxia type 2: the ATRIL trial
LuisVelázquez-PérezaRobertoRodrÃguez-Labradab
Advancing the diagnosis of repeat expansion disorders
Paul JLockhartab
The prognostic value of neurofilament light chain in serum
FinnSellebjergabMelindaMagyariab
CGRP-targeted drugs for migraine: still many uncertainties
Hans ChristophDienera
Expression of concern—Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study
Multiple sclerosis: two decades of progress
Bruce A CCreeaJorge ROksenbergaStephen LHausera
The reality of multiple sclerosis assessment in middle-income countries
Dimitri MarquesAbramovDaniel Souzade SilvaTania Regina SaadSallesPaulo RicardoGalhanoneVladimir VLazarev
The reality of multiple sclerosis assessment in middle-income countries – Authors' reply
ÀlexRoviraaAnthonyTraboulseebDaniel SReichcMike PWattjesdMAGNIMS Study Group, CMSC, and NAIMS
Brain health in the Philippines
Lorena Margarita BOsorioaMichelle Ann BEalaaJanine Patricia GRobredobJose Leonard RPascualcd
MOG antibody-associated disease after vaccination with ChAdOx1 nCoV-19
AnnaFrancisbJacquelinePalacebLarsFuggera
Karin Klijn: driven by a love of neurology and equality
PriyaVenkatesan
Brains are neither pink nor blue but fifty shades of grey matter
PeterRanscombe
Safety and efficacy of riluzole in spinocerebellar ataxia type 2 in France (ATRIL): a multicentre, randomised, double-blind, placebo-controlled trial
GiuliaCoarelliMDabAnnaHeinzmannMDabClaireEwenczykMDabClaraFischerMScdMarieChupinPhDcdMarie-LorraineMoninMDabHortenseHurmicMSabFabienneCalvasMDeProfPatrickCalvasMDfProfCyrilGoizetMDgProfStéphaneThoboisMDhijProfMathieuAnheimMDklmProfKarineNguyenMDnProfDavidDevosMDoProfChristopheVernyMDpVito A GRiciglianoMDaJean-FrançoisManginPhDcdProfAlexisBriceMDa…ProfAlexandraDurrMDab
Whole genome sequencing for the diagnosis of neurological repeat expansion disorders in the UK: a retrospective diagnostic accuracy and prospective clinical validation study
KristinaIbañezPhDabJamesPolkePhDc*R TannerHagelstromPhDd*EgorDolzhenkoPhDdDorotaPaskoPhDaEllen Rachel AmyThomasPhDaLouise CDaughertyMScaeDaliaKasperaviciutePhDabKatherine RSmithPhDab
Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study
PascalBenkertPhDa†StephanieMeierMScb†SabineSchaedelinMScaAliManouchehriniaPhDeÖzgürYaldizliMDbAleksandraMaceskiMScbJohannaOechteringMDbLutzAchtnichtsMDgDavidConenMDiTobiasDerfussMDbPatrice HLaliveMDlChristianMuellerMDdStefanieMüllerMDmYvonneNaegelinMDbJorge ROksenbergPhDnCarolinePotMDkAnkeSalmenMDhElineWillemsePhDb…ChiaraZecca
Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations
Bradley FBoeveMDaAdam LBoxerMDbFionaKumforPhDcdYolandePijnenburgMDeJonathan DRohrerPhDf
Management of atherosclerotic extracranial carotid artery stenosis
ProfLeo HBonatiMDaProfOlavJansenPhDbProfGert Jde BorstMDcProfMartin MBrownFRCPd
Calcitonin gene-related peptide-targeting drugs for migraine: how pharmacology might inform treatment decisions
LindaAl-HassanyMScaProfPeter JGoadsbyMDbcProfA H JanDanserPhDaProfAntoinetteMaassenVanDenBrinkPhDa
